
Opinion|Videos|September 13, 2024
Biosimilar Copay Programs
Author(s)Sophia Humphreys, PharmD, MHA
Dr Humphreys discusses biosimilar copay programs.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do copay programs impact the adoption of biosimilars for patients, and what role can the pharmacy staff play in educating patients about these programs?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Subcutaneous Isatuximab Could Compete With Daratumumab in Multiple Myeloma
2
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
3
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
4
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
5







































































































